Shunji Nakajima
R&D Center, 7-3-4 Higashi Machi, Ibukidai, Nishi Ku
Kobe, 6512242, Japan
Kobe, 6512242, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of Bifidobacterium longum CLA8013 on bowel movement improvement: a placebo-controlled, randomized, double-blind study.
Journal: Bioscience of microbiota, food and health
Published: October 07, 2022
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
Journal: Digestion
Published: August 10, 2022
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Journal: Journal of gastroenterology and hepatology
Published: November 27, 2020
The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study.
Journal: Life (Basel, Switzerland)
Published: August 20, 2020
Bifidobacterium bifidum G9-1 ameliorates soft feces induced by metformin without affecting its antihyperglycemic action.
Journal: Bioscience of microbiota, food and health
Published: September 04, 2019
Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis.
Journal: Microbiology and immunology
Published: June 13, 2019
Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis.
Journal: Bioscience of microbiota, food and health
Published: August 07, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026